BC
AGN

Bartlett & Co’s Allergan Inc AGN Stock Holding History

Bartlett & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-21
Closed -$5K – 704
2017
Q2 		$5K Hold
21
– – ﹤0.01% 624
2017
Q1 		$5K Sell
21
-442
-95% -$105K ﹤0.01% 650
2016
Q4 		$97K Hold
463
– – ﹤0.01% 319
2016
Q3 		$107K Sell
463
-31
-6% -$7.16K 0.01% 310
2016
Q2 		$114K Buy
494
+31
+7% +$7.15K 0.01% 304
2016
Q1 		$124K Hold
463
– – 0.01% 291
2015
Q4 		$145K Hold
463
– – 0.01% 278
2015
Q3 		$126K Buy
463
+222
+92% +$60.4K 0.01% 288
2015
Q2 		$73K Buy
+241
New +$73K ﹤0.01% 362
2015
Q1 		– Sell
-700
Closed -$149K – 854
2014
Q4 		$149K Hold
700
– – 0.01% 284
2014
Q3 		$125K Hold
700
– – 0.01% 291
2014
Q2 		$118K Buy
700
+100
+17% +$15.6K 0.01% 298
2014
Q1 		$74K Hold
600
– – ﹤0.01% 358
2013
Q4 		$67K Sell
600
-33
-5% -$3.15K ﹤0.01% 366
2013
Q3 		$57K Buy
633
+33
+6% +$2.96K ﹤0.01% 387
2013
Q2 		$51K Buy
+600
New +$62.2K ﹤0.01% 391

Other funds holding AGN

FIM
Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $552M AUM 26% 1-Year Est. Return
GAM
Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return
ARMC
American Research & Management Company Marion, Massachusetts $362M AUM 8.06% 1-Year Est. Return

Bartlett & Co's AGN Position: Q3 2017 in Review

Bartlett & Co sold out of Allergan Inc (AGN) in Q3 2017, closing a stake of 21 shares — an estimated $5K sold.

Bartlett & Co first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $149K in Q4 2014. 10 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Bartlett & Co reported no remaining Allergan Inc position as of Q3 2017 after selling out during the quarter.
  • Bartlett & Co sold 21 Allergan Inc shares in Q3 2017, an estimated $5K.
  • Bartlett & Co first reported a position in Allergan Inc in Q2 2013 and held it in 16 quarters.
  • Bartlett & Co's Allergan Inc position peaked at $149K in Q4 2014.
  • 10 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2017.

Based on Bartlett & Co's 13F filing for Q3 2017, filed 23 Oct 2017.